机译:Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple‐dose study
Bayer AG;
ClinStat GmbH;
CRS Clinical Research Services Wuppertal GmbH;
BAY 2433334; clinical trial; factor XIa; pharmacodynamics; pharmacokinetics; phase 1; safety; tolerability;